Cycurion, Inc. (CYCU): Nasdaq/NYSE listing notice — Q3 revenue $3.83M (down 14% YoY), net loss $3.24M, backlog >$80M, regains Nasdaq compliance

Cycurion, Inc.

Q3 revenue $3.83M (down 13.9% YoY), net loss $3.24M ($1.59 loss per share).
Contract backlog exceeds $80M; forecast Q1 2026 run-rate revenue $4.17M (annual ~$16.66M).
Regained compliance with Nasdaq minimum bid price; hearing canceled; stock continues trading.
Awarded contract by telecom to modernize emergency warning network (1,300+ sites, value >$1M).
Cash increased to $3.65M from $0.04M; total assets $32.31M; stockholders' equity $15.41M.

item 2.02 item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Cycurion, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5450(a)(1)

Exact text from the filing

November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained compliance with Nasdaq’s Bid Price Rule requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq Global Market’s listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market without interruption.

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Cycurion, Inc. filing history →

Source: SEC EDGAR

accession 0001868419-25-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.